Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Y
Alleghany Corp
Y
|
+$70.1M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$64.4M |
| 3 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$41.9M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$40.7M |
| 5 |
Warner Bros
WBD
|
+$37.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$103M |
| 2 |
PLAN
Anaplan, Inc.
PLAN
|
+$89.2M |
| 3 |
ANAT
American National Group, Inc. Common Stock
ANAT
|
+$44M |
| 4 |
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
|
+$33.9M |
| 5 |
MGP
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
|
+$20M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.8% |
| 2 | Financials | 13.02% |
| 3 | Healthcare | 11.9% |
| 4 | Consumer Discretionary | 10.28% |
| 5 | Industrials | 8.92% |
Similar funds
Paul Tudor Jones's Q2 2022 Portfolio in Review
As of Q2 2022, Paul Tudor Jones held 2,681 positions worth $3.81B, down 11% from $4.27B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Paul Tudor Jones deployed $332M of net new capital in Q2 2022, opening 766 new positions and adding to 644 existing holdings. Its largest new stake was Biohaven Pharmaceutical Holding Company Ltd.: 327,735 shares worth $47.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Liberty Broadband Class C, an estimated $18.4M trimmed.
- Paul Tudor Jones's largest Q2 2022 buy was Biohaven Pharmaceutical Holding Company Ltd.: 327,735 shares worth $47.8M.
- Paul Tudor Jones added most to Alleghany Corp in Q2 2022, an estimated $70.1M increase.
- Paul Tudor Jones's biggest Q2 2022 reduction was Liberty Broadband Class C, cutting an estimated $18.4M.
- Paul Tudor Jones fully exited Cerner Corp in Q2 2022, selling an estimated $103M.
- Paul Tudor Jones's ten largest holdings make up 10% of its $3.81B portfolio in Q2 2022.
- Paul Tudor Jones opened 766 new positions and closed 638 in Q2 2022.
- Paul Tudor Jones's portfolio value fell 11% quarter-over-quarter to $3.81B.
Based on Tudor Investment Corp's 13F filing for Q2 2022, filed 15 Aug 2022.